| Net income | 23.3M |
| Depreciation, depletion, and amortization | 49.7M |
| Other non-cash charges | -100K |
| Decrease (increase) in current assets | -500K |
| Decrease (increase) in noncurrent assets | -3.2M |
| Increase (decrease) in current liabilities | |
| Increase (decrease) in noncurrent liabilities | 4.8M |
| Net cash provided by (used in) operating activities | 98.7M |
| Capital expenditures | -87.7M |
| Investments in and advances to affiliates and joint ventures | -4.8M |
| Other | 900K |
| Net cash (used in) investing activities | -72.5M |
| Net change in outstanding debt | |
| Proceeds from sales of treasury stock | 7M |
| Dividends | -25.9M |
| Excess tax benefits from stock-based compensation | 200K |
| Net cash provided by (used in) financing activities | -18.4M |
| Effect of foreign currency rate changes on cash | 0 |
| Net increase (decrease) in cash and cash equivalents | 7.8M |
| Cash and cash equivalents at beginning of period | 40M |
| Cash and cash equivalents at end of period | 47.8M |